NYNihal Yildiz
Nihal Yildiz
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nihal Yildiz has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Ali Cansu
Department of Pediatric Neurology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
2 shared publications - Arife Derda Yücel Şen
Department of Pediatric Neurology, Faculty of Medicine, Eskişehir Osmangazi University, Eskisehir 26040, Turkey
2 shared publications - Ayşe Serdaroğlu
Department of Pediatric Neurology, Gazi University Faculty of Medicine, Ankara, Turkey
2 shared publications - Betül Kılıç
Department of Pediatric Neurology, Faculty of Medicine Istanbul Medipol University Istanbul Türkiye
2 shared publications - Esra Serdaroğlu
Department of Pediatric Neurology, Gazi University Faculty of Medicine, Ankara, Turkey
2 shared publications - Hasan Tekgül
Division of Pediatric Neurology, Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkiye
2 shared publications
Latest Publications
- 23 March 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 179, 111015
The efficacy and tolerability of lacosamide adjunctive therapy in children with drug-refractory epilepsy: A nationwide Turkish cohort study
- 23 March 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 179, 111015
The efficacy and tolerability of lacosamide adjunctive therapy in children with drug-refractory epilepsy: A nationwide Turkish cohort study
- 6 June 2022
- Published by Elsevier in Epilepsy Research
- Vol. 184, 106963
The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study
- 6 June 2022
- Published by Elsevier in Epilepsy Research
- Vol. 184, 106963
The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study